IDH2 and acute myeloid leukemia: Inhibitors of mutant IDH2 may reduce the level of 2-HG to reverse cell differentiation (49), and indirectly destroy the bone marrow microenvironment induced by 2-HG by blocking the proliferation of AML cells (21).